Literature DB >> 21708907

Protective conditioning of the brain: expressway or roadblock?

Philipp Mergenthaler1, Ulrich Dirnagl.   

Abstract

The brain responds to noxious stimulation with protective signalling. Over the last decades, a number of experimental strategies have been established to study endogenous brain protection. Pre-, per-, post- and remote 'conditioning' are now widely used to unravel the underlying mechanisms of endogenous neuroprotection. Some of these strategies are currently being tested in clinical trials to protect the human brain against anticipated damage or to boost protective responses during or after injury. Here we summarize the principles of 'conditioning' research and current efforts to translate this knowledge into effective treatment of patients. Conditioning to induce protected brain states provides an experimental window into endogenous brain protection and can lead to the discovery of drugs mimicking the effects of conditioning. Mechanisms of endogenous brain tolerance can be activated through a wide variety of stimuli that signal 'danger' to the brain. These danger signals lead to the induction of regulator and effector mechanisms, which suppress death and induce survival pathways, decrease metabolism, as well as increase substrate delivery. We conclude that preclinical research on endogenous brain protection has greatly benefited from conditioning strategies, but that clinical applications are challenging, and that we should not prematurely rush into ill-designed and underpowered clinical trials.

Entities:  

Mesh:

Year:  2011        PMID: 21708907      PMCID: PMC3180575          DOI: 10.1113/jphysiol.2011.209718

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  83 in total

1.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

Review 2.  Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning.

Authors:  Gregg L Semenza
Journal:  Biochim Biophys Acta       Date:  2010-08-21

3.  Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke.

Authors:  Arthur Liesz; Wei Zhou; Éva Mracskó; Simone Karcher; Henrike Bauer; Sönke Schwarting; Li Sun; Dunja Bruder; Sabine Stegemann; Adelheid Cerwenka; Clemens Sommer; Alexander H Dalpke; Roland Veltkamp
Journal:  Brain       Date:  2011-03       Impact factor: 13.501

Review 4.  Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.

Authors:  Michel Ovize; Gary F Baxter; Fabio Di Lisa; Péter Ferdinandy; David Garcia-Dorado; Derek J Hausenloy; Gerd Heusch; Jakob Vinten-Johansen; Derek M Yellon; Rainer Schulz
Journal:  Cardiovasc Res       Date:  2010-05-06       Impact factor: 10.787

5.  Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance.

Authors:  Michèle Bastide; Patrick Gelé; Olivier Pétrault; Qian Pu; Audrey Caliez; Emmanuel Robin; Dominique Deplanque; Patrick Duriez; Régis Bordet
Journal:  J Cereb Blood Flow Metab       Date:  2003-04       Impact factor: 6.200

6.  Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.

Authors:  Hans Erik Bøtker; Rajesh Kharbanda; Michael R Schmidt; Morten Bøttcher; Anne K Kaltoft; Christian J Terkelsen; Kim Munk; Niels H Andersen; Troels M Hansen; Sven Trautner; Jens Flensted Lassen; Evald Høj Christiansen; Lars R Krusell; Steen D Kristensen; Leif Thuesen; Søren S Nielsen; Michael Rehling; Henrik Toft Sørensen; Andrew N Redington; Torsten T Nielsen
Journal:  Lancet       Date:  2010-02-27       Impact factor: 79.321

Review 7.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

8.  Adaptation of adult brain tissue to anoxia and hypoxia in vitro.

Authors:  A Schurr; K H Reid; M T Tseng; C West; B M Rigor
Journal:  Brain Res       Date:  1986-05-28       Impact factor: 3.252

Review 9.  Sample size calculations in acute stroke trials: a systematic review of their reporting, characteristics, and relationship with outcome.

Authors:  Chris S Weaver; Jo Leonardi-Bee; Fiona J Bath-Hextall; Philip M W Bath
Journal:  Stroke       Date:  2004-03-18       Impact factor: 7.914

10.  TLR2 has a detrimental role in mouse transient focal cerebral ischemia.

Authors:  Gina Ziegler; Denise Harhausen; Claudia Schepers; Olaf Hoffmann; Christina Röhr; Vincent Prinz; Janett König; Hans Lehrach; Wilfried Nietfeld; George Trendelenburg
Journal:  Biochem Biophys Res Commun       Date:  2007-05-30       Impact factor: 3.575

View more
  19 in total

Review 1.  Ischemic conditioning-induced endogenous brain protection: Applications pre-, per- or post-stroke.

Authors:  Yuechun Wang; Cesar Reis; Richard Applegate; Gary Stier; Robert Martin; John H Zhang
Journal:  Exp Neurol       Date:  2015-04-18       Impact factor: 5.330

2.  Molecular mechanisms underlying neurovascular protection in stroke.

Authors:  Giovanni E Mann
Journal:  J Physiol       Date:  2011-09-01       Impact factor: 5.182

Review 3.  Novel Treatments in Neuroprotection for Aneurysmal Subarachnoid Hemorrhage.

Authors:  Robert F James; Daniel R Kramer; Zaid S Aljuboori; Gunjan Parikh; Shawn W Adams; Jessica C Eaton; Hussam Abou Al-Shaar; Neeraj Badjatia; William J Mack; J Marc Simard
Journal:  Curr Treat Options Neurol       Date:  2016-08       Impact factor: 3.598

4.  A functional role of the cyclin-dependent kinase inhibitor 1 (p21(WAF1/CIP1)) for neuronal preconditioning.

Authors:  Philipp Mergenthaler; Claudia Muselmann; Juliane Sünwoldt; Nickolay K Isaev; Tadeusz Wieloch; Ulrich Dirnagl; Andreas Meisel; Karsten Ruscher
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-09       Impact factor: 6.200

5.  Preconditioning the brain: moving on to the next frontier of neurotherapeutics.

Authors:  Sebastian Koch; Ralph L Sacco; Miguel A Perez-Pinzon
Journal:  Stroke       Date:  2012-03-29       Impact factor: 7.914

6.  Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state.

Authors:  Philipp Mergenthaler; Anja Kahl; Anne Kamitz; Vincent van Laak; Katharina Stohlmann; Susanne Thomsen; Heiko Klawitter; Ingo Przesdzing; Lars Neeb; Dorette Freyer; Josef Priller; Tony J Collins; Dirk Megow; Ulrich Dirnagl; David W Andrews; Andreas Meisel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-10       Impact factor: 11.205

Review 7.  Cerebral Ischemic Preconditioning: the Road So Far….

Authors:  N Thushara Vijayakumar; Amit Sangwan; Bhargy Sharma; Arshad Majid; G K Rajanikant
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

Review 8.  Pathogenic mechanisms following ischemic stroke.

Authors:  Seyed Esmaeil Khoshnam; William Winlow; Maryam Farzaneh; Yaghoob Farbood; Hadi Fathi Moghaddam
Journal:  Neurol Sci       Date:  2017-04-17       Impact factor: 3.307

Review 9.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

10.  A concerted appeal for international cooperation in preclinical stroke research.

Authors:  Ulrich Dirnagl; Antoine Hakim; Malcolm Macleod; Marc Fisher; David Howells; Stuart M Alan; Gary Steinberg; Anna Planas; Johannes Boltze; Sean Savitz; Costantino Iadecola; Stephen Meairs
Journal:  Stroke       Date:  2013-04-18       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.